|
⚲
|
| Keyboard |
| Rouan Sarah Kathryn
✚
|
|
|---|---|
| CIK # | 0001761366 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001761366] | |
| 4 | [0001761366] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Viking Therapeutics Inc | |
| Rouan Sarah Kathryn | |
| Navidea Biopharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-02 | Grant | 3,150 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 20,400 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-03-31 | Buy | 1,240 | $24.15 | 29,946 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2025-01-02 | Grant | 18,800 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-25 | Option exercise | 11,000 | $4.88 | 53,680 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-10-25 | Sell | 11,000 | $80.89 | 889,790 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2024-10-25 | Option exercise | 11,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2024-02-08 | Option exercise | 25,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-02-08 | Sell | 25,000 | $28.05 | 701,250 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-02-08 | Option exercise | 25,000 | $8.32 | 208,000 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-01-19 | Option exercise | 30,000 | $8.32 | 249,600 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-01-19 | Sell | 30,000 | $23.05 | 691,500 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2024-01-19 | Option exercise | 30,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2024-01-02 | Grant | 32,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2023-01-03 | Grant | 22,000 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2022-01-03 | Grant | 22,000 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2021-06-30 | Grant | 4,892 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Stock Option · derivative
|
2021-01-13 | Grant | 2,500 | $0.00 | |
|
Navidea Biopharmaceuticals Inc NAVB
Common Stock
|
2021-01-13 | Grant | 2,500 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2021-01-04 | Grant | 22,000 | $0.00 | |
| showing 20 of 29 most recent transactions | |||||